Literature DB >> 21454741

Commentary on an article by Hannu T. Aro, MD, PhD, et al.: "Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation".

Timothy Bhattacharyya1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454741      PMCID: PMC3084494          DOI: 10.2106/JBJS.K.00262

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  2 in total

1.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.

Authors:  Shunmugam Govender; Cristina Csimma; Harry K Genant; Alexandre Valentin-Opran; Yehuda Amit; Ron Arbel; Hannu Aro; Dan Atar; Michael Bishay; Martin G Börner; Philippe Chiron; Peter Choong; John Cinats; Brett Courtenay; Robert Feibel; Bernard Geulette; Charles Gravel; Norbert Haas; M Raschke; Eric Hammacher; D van der Velde; Philippe Hardy; Michael Holt; Christof Josten; Rupert Ludwig Ketterl; Bennie Lindeque; Günter Lob; Henry Mathevon; Gerald McCoy; D Marsh; Russell Miller; Everard Munting; Stein Oevre; L Nordsletten; Amratlal Patel; Anthony Pohl; William Rennie; Peter Reynders; Pol Maria Rommens; Jean Rondia; Willem C Rossouw; P J Daneel; Stephen Ruff; Axel Rüter; Seppo Santavirta; Thomas A Schildhauer; C Gekle; Reinhard Schnettler; David Segal; Hanns Seiler; Robert B Snowdowne; Jouwert Stapert; Gilbert Taglang; Rene Verdonk; Lucas Vogels; Arnulf Weckbach; Andreas Wentzensen; Tadeusz Wisniewski
Journal:  J Bone Joint Surg Am       Date:  2002-12       Impact factor: 5.284

2.  Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures.

Authors:  Mohit Bhandari; Gordon Guyatt; Paul Tornetta; Emil H Schemitsch; Marc Swiontkowski; David Sanders; Stephen D Walter
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.